Fri, Nov 28, 2014, 7:32 AM EST - U.S. Markets open in 1 hr 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Enzon Pharmaceuticals Inc. Message Board

  • one1badbilly one1badbilly Mar 29, 2013 10:14 AM Flag

    FWIW per share sale valuation estimate

    After looking things over I'd revise the royalties downward to $200M (this is likely too small as several items are not disclosed), it looks like there should be an accummulated loss of around $400M, at 35% that's $140M, and accummulating the last five years of R&D exspense ~$200M as the intellectual property value, throw in $75M cash and that's $615. Discount it 50% to $307M, and divide by the outstanding shares 44m, and you $7, if you divide by the float shares ~30m, you get $10. (Note the company went on a stock by back spree so a large number of authorized shares are sitting in the treasury. Why they did this, a ~$10 a share, and how many is not clear, it looks researchable but in any event a significant number of the outstanding shares are held by the company. I'm not an expert in these matters but I believe that portion of the sale value would be distributed to shareholders). A constructive critique of this analysis is welcomed.

    Per Share Valuation Estimate: $7-$10

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ENZN
1.08+0.01(+0.93%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.